Vertex Pharmaceuticals has been the apple of investors' search engines, but its recent stock dip of 3.3% might have folks ...

The stock's rise snapped a three-day losing streak.

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Morgan Stanley raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $462 from $459 and keeps an Equal Weight rating on the ...

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma ...

Jim Cramer recently sang praises for Vertex Pharmaceuticals, dubbing it “terrific” and lauding its “revolutionary anti pain ...

Vertex Pharmaceuticals Incorporated has a 52-week low of $377.85 and a 52-week high of $519.88. Vertex Pharmaceuticals ( NASDAQ:VRTX – Get Free Report ) last announced its quarterly earnings ...

In this article, we are going to look at where Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) stands against other biotech stocks. The biotechnology sector is gaining new momentum with better market ...